INFORMATION FOR THE USER
Bronchitol 40 mg powder for inhalation, hard capsules
Manitol
Read this entire prospect carefully before starting to use this medication, as it contains important information for you.
Contents of this prospect
What is Bronchitol
Bronchitol contains a medication called mannitol, which is a mucolytic.
What is Bronchitol used for
Bronchitol is used in adults 18 years and older. In addition to using Bronchitol, the patient will continue to take their usual medication for cystic fibrosis.
How Bronchitol works
Bronchitol is inhaled into the lungs to improve cystic fibrosis, a hereditary disease that affects the glands present in the lungs, intestine, and pancreas, which secrete fluids such as mucus and digestive juices.
Bronchitol helps to increase the amount of water present on the surface of the respiratory tract and in the mucus. In this way, the lungs can eliminate mucus more easily. It also helps to improve the condition of the lungs and breathing. As a result, a 'productive cough' may appear, which also helps to eliminate mucus from the lungs.
Do not use Bronchitol
If any of the above situations apply to you (or if you are unsure), consult your doctor or pharmacist before using this medication.
Warnings and precautions
Consult your doctor or pharmacist before using this medication.
Inhalation of medications can cause chest tightness and wheezing, in some cases immediately after taking the medication. Your doctor will help you take your first dose of Bronchitol and check your lung function before, during, and after administration. Your doctor may ask you to use other medications such as a bronchodilator before taking Bronchitol.
Inhalation of medications can also cause coughing, which may occur with Bronchitol. Consult your doctor if the cough does not go away or if it concerns you.
Children and adolescents
Bronchitol should not be used in children and adolescents under 18 years of age. This recommendation is due to the limited information available in this patient group.
Use of Bronchitol with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
You can continue to take your medications for cystic fibrosis when using Bronchitol, including inhaled antibiotics such as tobramycin and colistimethate sodium. If you have doubts, consult your doctor or pharmacist before taking Bronchitol.
Pregnancy and breastfeeding
Driving and operating machinery
It is unlikely that Bronchitol will affect your ability to drive or use tools or machines.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist.
Always take your bronchodilator before using Bronchitol.
Recommended dose
Adults 18 years of age or older
Initial dose
Before your doctor prescribes Bronchitol, your doctor will help you take your first dose of Bronchitol and perform a pulmonary function test at each step to check that you are not sensitive to mannitol. The first dose is taken in four steps:
Step 1 – 1 capsule (40 mg)
Step 2 – 2 capsules (80 mg)
Step 3 – 3 capsules (120 mg)
Step 4 – 4 capsules (160 mg)
At the end of the initial dose, you will have taken 10 capsules (400 mg), which is the normal dose.
Treatment dose (packs for 2 weeks)
Order for use of this medication
Use Bronchitol as part of your normal daily treatment routine. The suggested order is as follows, unless otherwise indicated by your doctor:
How to use Bronchitol
For instructions on using the inhaler, see the end of the prospectus.
If you use more Bronchitol than you should
If you think you have taken an excessive amount of medication, inform your doctor or pharmacist immediately. You may:
Your doctor will provide you with oxygen and medications to help you breathe.
If you forget to use Bronchitol
If you interrupt treatment with Bronchitol
If you interrupt treatment with Bronchitol, your symptoms may worsen. Do not stop using Bronchitol without first speaking with your doctor, even if you feel better. Your doctor will indicate how long you should use this medication.
If you have any other doubts about using this medication, ask your doctor or pharmacist.
Like all medicines, Bronchitol can cause side effects, although not everyone will experience them.
Stop using Bronchitol and consult a doctor immediately if you notice any of the following serious side effects:
Inform your doctor immediately if you notice any of the following side effects:
Other side effects are:
Common (may occur in more than 1 in 10 people)
Uncommon (may affect 1 in 100 people)
Reporting of side effects
If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the national notification system included in thescheme in theAppendix V*. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
Do not use Bronchitol after the expiration date that appears on the carton box and the blister pack after "CAD". The expiration date is the last day of the month indicated.
Store below 30°C.
Store in the original packaging to protect it from moisture.
Once removed from the blister pack, the capsule must be used immediately.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the containers and medicines you no longer need. This will help protect the environment.
Composition of Bronchitol
The active ingredient is mannitol. Each capsule contains 40 mg of mannitol. The average inhaled dose per capsule is 32.2 milligrams of mannitol.
Appearance of the product and contents of the pack
Bronchitol is a powder for inhalation in hard capsules. Bronchitol 40 mg powder for inhalation, hard capsules, is a white or almost white powder in hard, transparent, and colourless capsules with the inscription "PXS 40 mg". The powder is inhaled into the lungs with the inhaler supplied in the pack.
Each initial dose pack of Bronchitol contains 1 blister with 10 capsules and 1 inhaler. The initial dose pack is used for the initial dose evaluation with your doctor.
Each 2-week treatment pack of Bronchitol contains 28 blisters with 10 capsules each (280 capsules in total) and 2 inhalers. The 2-week treatment pack is for therapeutic use.
Marketing authorisation holder and responsible person for manufacturing
Pharmaxis Europe Limited, 108 Q House, Furze Road, Sandyford, Dublin 18, D18AY29, Ireland
Responsible person for manufacturing
MIAS Pharma Limited, Suite 1, Stafford House, Strand Road, Portmarnock, Co. Dublin, D13 WC83, Ireland or Arvato Supply Chain Solutions SE, Gottlieb-Daimler Straße 1, 33428 Harsewinkel, North Rhine-Westphalia, Germany.
You can request more information about this medicine by contacting the local representative of the marketing authorisation holder:
België/Belgique/Belgien Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Lietuva Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
???????? Pharmaxis Europe Limited Te.: + 353 (0) 1431 9816 | Luxembourg/Luxemburg Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Ceská republika 4 Life Pharma CZ, s.r.o. Tel: +420 244 403 003 | Magyarország Pharmaxis Europe Limited Tel.: + 353 (0) 1431 9816 |
Danmark Chiesi Pharma AB Tlf: + 46 8 753 35 20 | Malta Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Deutschland Chiesi GmbH Tel: +49 (0) 40 897 240 | Nederland Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Eesti Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Norge Chiesi Pharma AB Tlf: + 46 8 753 35 20 |
Ελλ?δα Chiesi Hellas A.E.B.E. Τηλ: + 30.210.617.97.63 | Österreich Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
España Chiesi España, S.A.U. Tel: +34 93 494 8000 | Polska IMED Poland Sp. z o. o. Tel: +48 22 663 43 10 |
France Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Portugal Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Hrvatska Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | România Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Ireland Cheisi Limited Tel: + 44 (0)161 488 5555 | Slovenija Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Ísland Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Slovenská republika 4 Life Pharma SK, s.r.o. Tel: + 420 244 403 003 |
Italia Chiesi Farmaceutici S.p.A Tel: +39 0521 2791 | Suomi/Finland Chiesi Pharma AB Tel: + 46 8 753 35 20 |
Κ?προς Chiesi Hellas A.E.B.E. Τηλ: + 30.210.617.97.63 | Sverige Chiesi Pharma AB Tel: + 46 8 753 35 20 |
Latvija Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | United Kingdom Cheisi Limited Tel: + 44 (0)161 488 5555 |
Date of the last revision of this leaflet: MM/YYYY.
Other sources of information
The detailed information on this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu.There are also links to other websites on rare diseases and orphan medicines.
------------------------------------------------------------------------------------------------------------------>
How to use the inhaler
The following diagram explains how the inhaler looks. Bronchitol capsules can only be used with the inhaler supplied in the pack.
Spinning Chamber: Spinning Chamber
Mouthpiece: Mouthpiece
Filter: Filter
Piercing Buttons: Piercing Buttons
Piercing Chamber: Piercing Chamber
Inhaler
The following steps explain how to use the inhaler. If you want more information on how to care for it, go to the end of the instructions.
| |
| |
| |
| |
| |
| |
| . |
| |
| |
| |
| |
|
Additional information on caring for the inhaler
Cleaning the inhaler -Normally the inhaler will administer the correct dose of medication for 7 days without the need for cleaning. If you need to clean it, follow these steps:
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.